Publication | Closed Access

In vivo antiproliferative effect of NS-187, a dual Bcr-Abl/Lyn tyrosine kinase inhibitor, on leukemic cells harbouring Abl kinase domain mutations

Hematological MalignancyLeukemic CellsMixed-phenotype Acute LeukemiaMalignant Blood DisorderImmunologyAnti-cancer AgentMedicineCell BiologyCancer ResearchTumor BiologyVivo Antiproliferative Effect